Article ID Journal Published Year Pages File Type
2840236 Clínica e Investigación en Arteriosclerosis 2006 14 Pages PDF
Abstract
Stroke prevention is unequivocally based on the treatment of hypertension, which drastically reduces the risk of both a first stroke and recurrence. This reduced risk is largely dependent on simply reducing blood pressure values, although there may be differences among drugs. However other factors also influence the risk of stroke. This is the case of cholesterol: its treatment with statins has been shown to be beneficial both in primary and secondary prevention in patients at high risk. The same is true of antiaggregants, which could play a similar preventive role, while anticoagulants are only indicated in the prevention of embolic stroke. Lastly, the probable benefit (not scientifically proven) of interventions based on lifestyle changes should be mentioned.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Physiology
Authors
,